Follow
P23 Evaluation of safety parameters and dystrophin expression by sequential administration of exon-skipping and gene therapy in a DMDmdx mouse model. https://www.nmd-journal.com/article/S0960-8966(23)00330-9/pdf #Morpholino
P23 Evaluation of safety parameters and dystrophin expression by sequential administration of exon-skipping and gene therapy in a DMDmdx mouse model. https://www.nmd-journal.com/article/S0960-8966(23)00330-9/pdf #Morpholino